Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Elucid

Elucid Launches PlaqueIQ Image Analysis Software for the Carotid Arteries
From Elucid
Via Business Wire
Elucid’s PlaqueIQ™ Image Analysis Software Now Covered by United Healthcare
From Elucid
Via Business Wire
Elucid Names Richard E. Kuntz, MD, MSc and Shamiram Feinglass, MD, MPH Board Directors
From Elucid
Via Business Wire
Elucid Applauds CMS Inclusion of Coronary CTA with Plaque Analysis in 2026 Proposed Medicare Physician Fee Schedule
From Elucid
Via Business Wire
Elucid’s PlaqueIQ™ Image Analysis Software Included in EviCore Coverage Guidelines
From Elucid
Via Business Wire
Elucid to Showcase PlaqueIQ™ at SCCT 2025
From Elucid
Via Business Wire
Elucid Appoints Dr. Robert Pelberg as New Senior Vice President of Medical Affairs
From Elucid
Via Business Wire
Elucid Adds Clinical and Commercial Leadership Ahead of PlaqueIQ™ Launch
From Elucid
Via Business Wire
Elucid Announces Fifth Medicare Administrative Contractor to Cover AI Coronary Plaque Analysis
From Elucid
Via Business Wire
Elucid Announces Favorable Medicare Coverage of AI Coronary Plaque Analysis
From Elucid
Via Business Wire
Elucid Receives U.S. 510(k) Clearance of PlaqueIQ™ Image Analysis Software to Aid Cardiovascular Disease Assessment
From Elucid
Via Business Wire
Elucid Names Kelly Huang as CEO
From Elucid
Via Business Wire
Elucid Commences International PRE-VUE CCT Registry Study
From Elucid
Via Business Wire
Elucid Moves into New Headquarters in Preparation for Commercial Launch
From Elucid
Via Business Wire
Elucid Raises $80 Million in Series C Round Led by Elevage Medical Technologies
From Elucid
Via Business Wire
Elucid Announces American Medical Association (AMA) Instates CPT Code for Lipid-Rich Necrotic Core Quantification to Assess Atherosclerotic Plaque Stability
From Elucid
Via Business Wire
Elucid Eyes Big Opportunity to Save Lives with Software Amidst Major Guideline Changes
From Elucid
Via Business Wire
Elucid Presents Data Demonstrating Its AI Software Can Uniquely Quantify Key Drivers of Heart Attack and Stroke from Computed Tomography
From Elucid
Via Business Wire
Elucid Secures $8 Million in Series A Funding Led by MedTex Ventures and Global Health Impact Fund
From Elucid
Via Business Wire
Elucid Presents Results of the EVAPORATE Study at ESC Preventive Cardiology 2021 Late Breakers
From Elucid
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.